A recall on Ferring Pharmaceuticals ‘ intranasal desmopressin compounds — used to treat mild to moderate hemophilia A and von Willebrand disease type 1 — is expected to affect the availability of these products until at least mid- to late-2021, according to an advisory from the World Federation of Hemophilia. August 6, 2020 Ohio Legal Updates, ... Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. Recalled on August-25-2020. These products are being recalled due to superpotency or amounts of desmopressin higher than specified. It is possible that the product may contain elevated amounts of desmopressin acetate, the active pharmaceutical ingredient, and benzalkonium chloride, a preservative. The recall began January 15, 2020. Affects Food 4 Less stores. Reason: Product may contain undeclared MILK, and if eaten, could result in a severe allergic reaction to those sensitive to MILK. August 11, 2020 Stimate Recall Update – CSL Behring & Ferring Pharmaceuticals Response to HFA-NHF Letter, Voluntary Recall Due to “Superpotency” Ferring Pharmaceuticals issued a voluntary recall of Stimate (desmopressin) nasal spray due to “superpotency” – in other words, amounts of desmopressin being higher than specified. October 23, 2020 This recall was issued due to superpotency or amounts of desmopressin higher than specified, … These out of specification results … On August 5, 2020, CSL Behring, the manufacturer of STIMATE ® (desmopressin acetate) Nasal Spray, issued a voluntary recall of all lots on the market. In mid-August, the European Haemophilia Consortium (EHC) communicated an international recall of all FerringPharmaceuticals Limited nasal sprays containing desmopressin, including Octim®, Octostim®, Desmospray®, DDAVP Spray® and Stimate®, and reported that this may lead to shortages over the course of 2020. Find 2020 Ford F-150 recalls information, reported by the NHTSA, and we will help you find a nearby service center where you can get your car fixed. Use our VIN lookup tool to check for recalls on your car, or search by make and model. Notes: Owners may also contact the National Highway Traffic Safety Administration Vehicle Safety Hotline at 1-888-327-4236 (TTY 1-800-424-9153), or go to www.safercar.gov. Ferring US issues Voluntary Nationwide Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL Due to Superpotency. On October 28, 2020, this Safety Recall was amended to include a total of approximately 2,760,500 vehicles. This recall was issued due to superpotency or amounts of desmopressin higher than specified. If Stimate is part of your treatment plan, please contact your medical team for further discussion regarding your individual care. August 5, 2020. This recall is due to superpotency, or amounts of desmopressin in … Three weeks after recalling numerous lots of desmopressin nasal sprays in the UK and a number of other countries, Ferring has issued a recall of all lots of DDAVP 10 mcg/0.1ml, Stimate 1.5 mg/ml, and generic desmopressin 10 mcg/0.1ml nasal sprays in the US “due to superpotency or amounts of desmopressin higher than specified.” The recall includes 6 lots of DDAVP, 15 lots of Stimate, and … St imate® Nasal Spray is owned and manufactured by Ferring All lots of DDAVP Nasal Spray 10 mcg/0.1 ml, Desmopressin Acetate nasal Spray 10 mcg/0.1 ml, and STIMATE Nasal Spray 1.5 mg/ml listed in the table are recalled. Immediately following the issuance of medical advisories to the community regarding the recall of Stimate® (desmopressin nasal spray) a product used to control bleeding in patients with von Willebrand disease and hemophilia A, the National Hemophilia Foundation and Hemophilia Federation of America sent a joint letter to CSL Behring, which sells and distributes Stimate® in the US and Ferring … December 9, 2020 Fiskars Brands Recalls 16 Foot Pole Saw/Pruners Due to Laceration Hazard Sold at: Walmart.com. On August 26, 2020, the U.S. Food and Drug Administration (FDA) announced that Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL and STIMATE® Nasal Spray 1.5 mg/mL listed at the website below as a Class I Recall. (July 22, 2020, updated August 15, 2020) Last month, the Coalition for Hemophilia B reported on a voluntary recall of specific lots of Stimate desmopressin acetate nasal spray manufactured by Ferring Pharmaceuticals and distributed in the United States by CSL Behring. August 05, 2020 -- Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL listed in the table below to the consumer level. A3: When this Safety Recall was first announced on January 13, 2020, there were approximately 564,300 vehicles covered. On July 21, CSL Behring and Ferring Pharmaceuticals announced a recall of multiple lots of Stimate (desmopressin), in the United States and in other countries around the world. July 21, 2020 Ferring Pharmaceuticals has issued a voluntary recall of all Stimate (desmopressin acetate) nasal spray 1.5mg/mL distributed and sold by CSL Behring LLC. CDC Seeks Perspectives on Living with Chronic Pain Find Recalls from December 2020 on ConsumerAffairs. This marks an expansion of Ferring’s initial July 2020 plans to conduct a narrower pharmacy-level recall. After further collaboration with the FDA, Ferring is now extending the recall to the consumer … Our list of Recalls includes automotive, appliance, food, technology, clothing, and more. Owners may contact Merritt customer service at 1-317-409-0146. On August 5, 2020, Ferring Pharmaceuticals announced a recall of three nasal sprays due to superpotency of the ingredients. December 2, 2020 Huffy Recalls Torex Ride-on Toy UTVs Due to Injury Hazard On August 12, 2020, CSL Behring issued a consumer-level recall of all lots on the market of STIMATE® Nasal Spray 1.5 mg/mL NDC # 00053-6871-00 manufactured by Ferring Pharmaceuticals and distributed and sold by CSL Behring. FRITO LAY PARTY MIX 28CT, 27.25 OZ. CSL Behring and Ferring Pharmaceuticals, Inc have responded to the joint NHF-NHF letter of July 22, 2020, regarding a recent recall of Stimate (desmopressin) nasal spray. Aug 13, 2020. Ferring US issues Voluntary Nationwide Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 … Please read if you use Stimate. Ferring Pharmaceuticals US announced a voluntary, nationwide recall of DDAVP nasal spray 10 mcg/0.1mL, desmopressin acetate nasal spray 10 mcg/0.1mL, and STIMATE nasal spray 1.5 mg/mL after routine testing found levels of desmopressin higher than specified. Statement from CSL Behring: Ferring Pharmaceuticals, Inc., is initiating a precautionary voluntary recall of all batches of Stimate® Nasal Spray (desmopressin acetate) 1.5 mg/mL. CSL Behring and Ferring Pharmaceuticals have announced additional information about a recent recall of lots of Stimate that was originally issued July 21, 2020. The risks associated with superpotency relate to abnormally low levels of sodium in the blood, which could eventually lead to … August 05, 2020 -- Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL listed in the table below to the consumer level. The recalled products are … The recall covers certain 2012 and 2013 Sorento SUVs, 2012 through 2015 Forte and Forte Koup cars, and 2011 through 2013 Optima Hybrid cars. Stimate® Batch Numbers: See chart below NDC Number: 0053-6871-00 Dear Customer: This updated letter is to provide you with additional information regarding the Stimate® Nasal Spray recall communication that was sent to you on July 21, 2020. Recalled on August-28-2020. Stimate is manufactured by Ferring Pharmaceuticals Inc. and is distributed and sold in the United States by CSL Behring. On March 4, 2020, this Safety Recall was amended and covered a total of approximately 1,433,050 vehicles. August 5, 2020 - Ferring Pharmaceuticals announced a voluntary, consumer-level recall of several lots of DDAVP®, desmopressin acetate, and Stimate® nasal spray products due to superpotency or amounts of desmopressin higher than specified. We have learned of a pharmacy level product recall of Stimate (desmopressin) nasal spray manufactured by Ferring Pharmaceuticals, and distributed in the U.S. by CSL Behring. According to the recall, these products are being recalled because testing revealed the presence of higher than specified amounts of a drug called desmopressin. More on the FDA website . December 10, 2020 Thermo Tents Recalls Mór Series Tents Due to Fire Hazard; Tents are Mislabeled as Fire Retardant Sold at: Walmart and Walmart.com. Click here for Medical Advisory #426. To provide better service in alerting the American people to unsafe, hazardous or defective products, six federal agencies with vastly different jurisdictions have joined together to create www.recalls.gov -- a "one stop shop" for U.S. Government recalls. Stimate Nasal Spray is owned and manufactured by Ferring Pharmaceuticals Inc., and is distributed and sold in the United States by CSL Behring. Aug 6, 2020 10:01 AM Recall of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE Nasal Spray 1.5 mg/mL by Ferring Pharmaceuticals US due to superpotency. Ferring Pharmaceuticals announced it was extending the recall of Stimate (desmopressin) to the consumer/user level. An important update regarding the pharmacy level product recall of Stimate (desmopressin) nasal spray. On August 5, 2020, the Federal Drug Administration (FDA) announced a voluntary recall by Ferring US on all lots of DDAVP (desmopressin acetate) nasal spray (10mcg/0.1mL, 5mL), desmopressin acetate nasal spray (10mcg/0.1mL, 5mL), and STIMATE nasal spray (1.5mg/mL, 2.5mL). Also, get recall information on car seats, tires and equipment. Read more about Stimate Recall Update; August 6, 2020.